Pharmacokinetics, Safety, and Tolerability of GLPG0259, a Mitogen-Activated Protein Kinase-Activated Protein Kinase 5 (MAPKAPK5) Inhibitor, Given as Single and Multiple Doses to He...

por Namour, Florence, Vanhoutte, Frédéric P., Beetens, Johan, Blockhuys, Stan, Weer, Marc De, Wigerinck, Piet
Publicado 2012

Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects

por Namour, Florence, Galien, René, Van Kaem, Tim, Van der Aa, Annegret, Vanhoutte, Frédéric, Beetens, Johan, van't Klooster, Gerben
Publicado 2016

GLPG1205, a GPR84 Modulator: Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects

por Timmis, Helen, Van Kaem, Tim, Desrivot, Julie, Dupont, Sonia, Meuleners, Luc, Beetens, Johan, Helmer, Eric, Santermans, Eva, Huettner, Silke
Publicado 2021

Phase 1 and 2 Randomized Clinical Studies Determine Lack of Efficacy for Anti-IL-17C Antibody MOR106 in Moderate–Severe Atopic Dermatitis

por Thaçi, Diamant, Singh, Dave, Lee, Mark, Timmis, Helen, Jacobs, Dominique, Passier, Paul, Rohrer, Susanne, Beetens, Johan, Phung, De, Sondag, Eric, Babic, Goran, Würth, Guido, Kloepfer, Pia, Härtle, Stefan, Hüttner, Silke
Publicado 2022